Recent developments with live-attenuated recombinant paramyxovirus vaccines

A Decade of Respiratory Syncytial Virus Epidemiology and Prophylaxis: Translating Evidence into Everyday Clinical Practice

(2016) Bosco A Paes et al.   Canadian Respiratory Journal

Palivizumab for immunoprophylaxis of respiratory syncitial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses

(2014) D Wang et al.   HEALTH TECHNOLOGY ASSESSMENT

Human Metapneumovirus (HMPV) Binding and Infection Are Mediated by Interactions between the HMPV Fusion Protein and Heparan Sulfate

(2012) A. Chang et al.   JOURNAL OF VIROLOGY

Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine

(2011) Paolo Durando et al.   Human vaccines & immunotherapeutics

Local cytokine response upon respiratory syncytial virus infection

(2011) Susan M. Bueno et al.   IMMUNOLOGY LETTERS

Ten years of human metapneumovirus research

(2011) F. Feuillet et al.   JOURNAL OF CLINICAL VIROLOGY

Identification of nucleolin as a cellular receptor for human respiratory syncytial virus

(2011) Farnoosh Tayyari et al.   NATURE MEDICINE

Phase 1 Study of the Safety and Immunogenicity of a Live, Attenuated Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Vaccine in Seronegative Children

(2011) David I. Bernstein et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997–2006

(2011) Lauren J. Stockman et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

A Randomized Controlled Trial of Motavizumab Versus Palivizumab for the Prophylaxis of Serious Respiratory Syncytial Virus Disease in Children With Hemodynamically Significant Congenital Heart Disease

(2011) Timothy F Feltes et al.   PEDIATRIC RESEARCH

Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers

(2011) K. A. Swanson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Progress in Respiratory Virus Vaccine Development

(2011) Alexander Schmidt   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Sendai virus-based RSV vaccine protects African green monkeys from RSV infection

(2011) Bart G. Jones et al.   VACCINE

Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years

(2011) Peter L. Collins et al.   VIRUS RESEARCH

Progress in the development of human parainfluenza virus vaccines

(2011) Alexander C Schmidt et al.   Expert Review of Respiratory Medicine

Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model

(2010) Marie-Eve Hamelin et al.   ANTIVIRAL RESEARCH

Mode of action of adjuvants: Implications for vaccine safety and design

(2010) Béatris Mastelic et al.   BIOLOGICALS

Respiratory syncytial virus disease: update on treatment and prevention

(2010) Leonard R Krilov   Expert Review of Anti-Infective Therapy

Population‐Based Incidence of Human Metapneumovirus Infection among Hospitalized Children

(2010) John V. Williams et al.   JOURNAL OF INFECTIOUS DISEASES

Assembly and Biological and Immunological Properties of Newcastle Disease Virus-Like Particles

(2010) L. W. McGinnes et al.   JOURNAL OF VIROLOGY

Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins

(2010) L. W. McGinnes et al.   JOURNAL OF VIROLOGY

Virologically Confirmed Population-based Burden of Hospitalization Caused by Respiratory Syncytial Virus, Adenovirus, and Parainfluenza Viruses in Children in Hong Kong

(2010) Susan S. Chiu et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Risk Factors in Children Hospitalized With RSV Bronchiolitis Versus Non-RSV Bronchiolitis

(2010) C. G. Garcia et al.   PEDIATRICS

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

(2010) J. DeVincenzo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys

(2010) Anne Schaap-Nutt et al.   VACCINE

Soluble recombinant human metapneumovirus G protein is immunogenic but not protective

(2010) Alex B. Ryder et al.   VACCINE

AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats

(2010) Akihito Sawada et al.   VACCINE

Structure of the Newcastle disease virus F protein in the post-fusion conformation

(2010) Kurt Swanson et al.   VIROLOGY

Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice

(2009) Yuanhui Fu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Bimolecular Complementation of Paramyxovirus Fusion and Hemagglutinin-Neuraminidase Proteins Enhances Fusion: Implications for the Mechanism of Fusion Triggering

(2009) S. A. Connolly et al.   JOURNAL OF VIROLOGY

Incubation periods of acute respiratory viral infections: a systematic review

(2009) Justin Lessler et al.   LANCET INFECTIOUS DISEASES

PHASE-I STUDY MEDI-534, OF A LIVE, ATTENUATED INTRANASAL VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS AND PARAINFLUENZA-3 VIRUS IN SEROPOSITIVE CHILDREN

(2009) Margarita Gomez et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial

(2009) X. Carbonell-Estrany et al.   PEDIATRICS

Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein

(2009) D. Roymans et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Integrin  v 1 promotes infection by human metapneumovirus

(2009) G. Cseke et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV

(2009) Bart Jones et al.   VACCINE

Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans

(2009) Joshua M. DiNapoli et al.   VACCINE

Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients

(2008) A Safdar   BONE MARROW TRANSPLANTATION

Hospitalization rates for human metapneumovirus infection among 0- to 3-year-olds in Gipuzkoa (Basque Country), Spain

(2008) G. CILLA et al.   EPIDEMIOLOGY AND INFECTION

Role of retinoic acid inducible gene-I in human metapneumovirus-induced cellular signalling

(2008) S. Liao et al.   JOURNAL OF GENERAL VIROLOGY

Human Parainfluenza Virus Type 1 C Proteins Are Nonessential Proteins That Inhibit the Host Interferon and Apoptotic Responses and Are Required for Efficient Replication in Nonhuman Primates

(2008) E. J. Bartlett et al.   JOURNAL OF VIROLOGY

Low-pH-Induced Membrane Fusion Mediated by Human Metapneumovirus F Protein Is a Rare, Strain-Dependent Phenomenon

(2008) S. Herfst et al.   JOURNAL OF VIROLOGY

Low-pH Triggering of Human Metapneumovirus Fusion: Essential Residues and Importance in Entry

(2008) R. M. Schowalter et al.   JOURNAL OF VIROLOGY

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

(2008) Maria Florencia Delgado et al.   NATURE MEDICINE

Effectiveness of Maternal Influenza Immunization in Mothers and Infants

(2008) K. Zaman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development of a PIV-vectored RSV vaccine: Preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults

(2008) Roderick S. Tang et al.   VACCINE

Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections

(2008) Xiaoyan Zhan et al.   VACCINE

Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques

(2008) Sander Herfst et al.   VACCINE

Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters

(2008) Jeanne H Schickli et al.   Virology Journal

Human Metapneumovirus Glycoprotein G Inhibits Innate Immune Responses

(2008) Xiaoyong Bao et al.   PLoS Pathogens